PrognomiQ is a California-based biotechnology company that develops transformative test products for the early detection and treatment of cancer.
$34M
Nov 04, 2024
-
NovAliX is a France-based CRO that provides services such as drug discovery, process optimization, protein production and preclinical testing for the pharmaceutical industry.
-
Aug 06, 2024
-
Frequently Asked Questions about Bruker
What is Bruker investing in?
Bruker has invested in 19 companies including Olaris, Recipe and Terrain Biosciences
What company did Bruker invest in?
Bruker invested in a total 19 companies including Olaris, Recipe and Terrain Biosciences
What are the top 5 investments by Bruker?
The top companies in which Bruker invested are Olaris, Recipe, Terrain Biosciences, PrognomiQ and NovAliX